Cardlytics (CDLX) Tops Q3 EPS by 42c

Cardlytics (NASDAQ: CDLX) reported Q3 EPS of ($0.15), $0.42 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $67.06 million versus the consensus estimate of $57.71 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• CFRA Starts SpaceX (SPCX) at Sell, 'Our primary concern is that SpaceX’s long-term strategy remains heavily dependent on Starship'
• Robinhood experiences service disruptions amid record traffic
• As America's Markets Reach Historic Highs, ELEKTROS Inc. Believes the Electrification Revolution Is Creating a New Generation of Opportunity